Therapeutic canine immunoglobulins and methods of using same
US9580496B2 · kind B2 · utility
16Cited by
3References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 8, 2012 |
| Grant date | Feb 28, 2017 |
| Priority date | — |
| Expiry date | Aug 19, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preparing a canine antibody suitable for use in the therapeutic treatment of a canine is provided. In particular, there is provided immunoglobulins which can be selected for the characteristic of whether they mediate downstream complement mediated immune activation when bound to a target antigen. Canine derived antibodies comprising specific heavy chain isotypes are provided. The invention extends to the use of the immunoglobulins of the invention in methods of treating conditions such as pain, inflammatory conditions and cancerous conditions in a canine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.